secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axe Compute Inc. (AGPU)
CIK:        0001446159
Form:       8-K
Filed at:   2023-11-14T23:59:59+00:00
Accession:  0001171843-23-007073
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Predictive Oncology narrows Q3 net loss 22% to $3.2M; revenue rises 57% to $715K
--------------------------------------------------------------------------------

- Net loss of $3.2M ($0.78 per share) vs $4.1M ($1.04) in Q3 2022, a 22% reduction.
- Revenue of $715,056, up 57% YoY, driven by higher sales of 3-D models.
- Gross margin improved to 85% from 76%; G&A expenses decreased $704K to $2.58M.
- Cash and equivalents $11.9M (down from $22.1M at Dec 31, 2022); equity $11.7M.
- Milestone: accurately predicted cancer types responsive to CRH's glutaminase inhibitors; ovarian cancer study with UPMC.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446159/000117184323007073/0001171843-23-007073-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446159/000117184323007073/f8k_111323.htm
  HTML page:      https://secwatch.observer/filing/0001171843-23-007073

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer